GSK Seeks Final Approval For $40M Paxil Settlement
GlaxoSmithKline PLC is close to finalizing a $40 million settlement for thousands of health care funds and insurance companies that paid for the anxiety drug Paxil for patients under the age...To view the full article, register now.
Already a subscriber? Click here to view full article